Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer
出版年份 2020 全文链接
标题
Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 8, Issue 2, Pages e000351
出版商
BMJ
发表日期
2020-07-17
DOI
10.1136/jitc-2019-000351
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Indoleamine Dioxygenase Inhibitors: Clinical Rationale and Current Development
- (2019) Mayanne M. T. Zhu et al. Current Oncology Reports
- Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab
- (2019) Ou Yamaguchi et al. Thoracic Cancer
- IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma
- (2019) Alex B. Blair et al. JOURNAL OF CLINICAL INVESTIGATION
- Integration of radiation and immunotherapy in breast cancer - Treatment implications
- (2018) Jason C. Ye et al. BREAST
- IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma
- (2018) Erik Ladomersky et al. CLINICAL CANCER RESEARCH
- Radiation therapy and immunotherapy: what is the optimal timing or sequencing?
- (2018) Maureen L Aliru et al. Immunotherapy
- Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response
- (2018) Xuanwei Zhang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Evolving Role of Radiation in Pancreatic Cancer
- (2018) Evan Landau et al. SURGICAL CLINICS OF NORTH AMERICA
- Abstract 4282: Deconvolution of plasma-derived exosomes for tracking and prediction of immunotherapy across multiple tissues
- (2018) Alvin Shi et al. CANCER RESEARCH
- Epacadostat (E) plus pembrolizumab (P) versus pembrolizumab alone in patients (pts) with unresectable or metastatic melanoma: Results of the phase 3 ECHO-301/KEYNOTE-252 study.
- (2018) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
- (2018) Tara C. Mitchell et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer
- (2018) Shravanti Macherla et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer
- (2018) Emmett V. Schmidt Seminars in Immunopathology
- Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment
- (2017) Yuki Muroyama et al. Cancer Immunology Research
- T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma
- (2017) Ingunn M. Stromnes et al. Cancer Immunology Research
- Checkpoint Antibodies but not T Cell-Recruiting Diabodies Effectively Synergize with TIL-Inducing -Irradiation
- (2016) M. Hettich et al. CANCER RESEARCH
- Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies
- (2016) A. M. Monjazeb et al. CLINICAL CANCER RESEARCH
- Use of a positional therapy device significantly improves nocturnal gastroesophageal reflux symptoms
- (2016) S. Allampati et al. DISEASES OF THE ESOPHAGUS
- PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
- (2016) Abul Azad et al. EMBO Molecular Medicine
- Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
- (2016) Pascal Hammel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6Clow F4/80+ Extratumoral Macrophages
- (2015) Gregory L. Beatty et al. GASTROENTEROLOGY
- Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models
- (2015) Daniel L.J. Thorek et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501
- (2015) Naoyuki Nogami et al. LUNG CANCER
- Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer
- (2015) Kelly Foley et al. Science Signaling
- Small molecule drugs with immunomodulatory effects in cancer
- (2015) Adrian G Murphy et al. Human Vaccines & Immunotherapeutics
- Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer
- (2015) Kelly Foley et al. Science Signaling
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
- (2014) Encouse B Golden et al. OncoImmunology
- Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated
- (2013) Michael D. Chuong et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell-Mediated Killing
- (2013) H. Liang et al. JOURNAL OF IMMUNOLOGY
- 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades
- (2013) Jin He et al. HPB
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study
- (2010) Jean-Luc Van Laethem et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic effects of local radiotherapy
- (2009) Silvia C Formenti et al. LANCET ONCOLOGY
- Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital
- (2008) Joseph M. Herman et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of Indoleamine 2,3-Dioxygenase in Metastatic Pancreatic Ductal Adenocarcinoma Recruits Regulatory T Cells to Avoid Immune Detection
- (2008) Agnes Witkiewicz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started